Orchestra BioMed (OBIO) Institutional Ownership $2.74 -0.21 (-7.12%) Closing price 04:00 PM EasternExtended Trading$2.74 +0.00 (+0.18%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$16.60MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$331.80K Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127% 5/13/2025 HighTower Advisors LLC61,000$261K0.0%-10.9%0.159% 5/12/2025 Nuveen LLC41,729$179K0.0%N/A0.109% 5/9/2025 Deutsche Bank AG20,219$87K0.0%+67.3%0.053% 5/5/2025 IFP Advisors Inc161,921$693K0.0%+106.4%0.423% 2/17/2025 Millennium Management LLC21,513$86K0.0%N/A0.057% 2/17/2025 Citadel Advisors LLC12,279$49K0.0%-39.0%0.032% 2/17/2025 Bank of America Corp DE23,780$95K0.0%+42.0%0.063% 2/14/2025 Boxer Capital Management LLC238,193$953K0.1%N/A0.627% 2/14/2025 Northern Trust Corp236,761$947K0.0%+2.5%0.623% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097% 2/14/2025 Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282% 2/13/2025 Barclays PLC37,786$152K0.0%+18.9%0.099% 2/13/2025 Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035% 2/12/2025 Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506% 2/12/2025 JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130% 2/7/2025 HighTower Advisors LLC68,500$274K0.0%+34.3%0.180% 1/17/2025 SG Americas Securities LLC12,785$51K0.0%+26.0%0.034% 11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024 Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024 Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024 State Street Corp429,613$2.21M0.0%+12.4%1.130% 11/15/2024 RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% 11/13/2024 The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088% 11/12/2024 Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% 11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024 The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024 Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024 Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024 New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023 Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out.10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023 Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023 Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023 RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023 IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 33 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Geode Capital Management LLC ($2.29M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), and Boxer Capital Management LLC ($953K).Learn more on OBIO's institutional investors. What percentage of Orchestra BioMed stock is owned by institutional investors? 53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed stock? Of the 27 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 3,504,594 shares in the last 24 months. This purchase volume represents approximately $18.34M in transactions. Which Orchestra BioMed major shareholders have been selling company stock? Of the 9 institutional investors that sold Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($225.36K), Price T Rowe Associates Inc. MD ($77.03K), Goldman Sachs Group Inc. ($13.41K), The Manufacturers Life Insurance Company ($8.78K), New York State Common Retirement Fund ($7.93K), Citadel Advisors LLC ($7.84K), and SkyView Investment Advisors LLC ($7.72K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 360,264 shares in the last 24 months. This volume of shares sold represents approximately $2.25M in transactions. Related Companies CLPT Institutional Ownership SMLR Institutional Ownership NNOX Institutional Ownership SMTI Institutional Ownership STIM Institutional Ownership SNWV Institutional Ownership ZIMV Institutional Ownership NVRO Institutional Ownership TCMD Institutional Ownership SKIN Institutional Ownership This page (NASDAQ:OBIO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OBIO Stock Free OBIO Stock Alerts